US Broker Ratings

Sonida Senior Living, Inc. (SNDA): Investor Outlook on a Healthcare Growth Story with 31% Revenue Surge

Sonida Senior Living, Inc. (SNDA), a prominent player in the healthcare sector under the Medical Care Facilities industry, is drawing attention with a remarkable 31% revenue growth. Based in Dallas,..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Navigating a Challenging Landscape with an 84% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector, specializes in drug manufacturing with a focus on specialty and generic solutions. The company’s portfolio is diverse, offering..

Verastem, Inc. (VSTM) Stock Analysis: Exploring the 221% Potential Upside in Biotech Investment

Verastem, Inc. (NASDAQ: VSTM) presents an intriguing opportunity for investors with its significant potential upside of over 221%, according to analyst ratings. As a biopharmaceutical company at the forefront of..

Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Growth Potential with a 15.94% Upside

Fulgent Genetics, Inc. (NASDAQ: FLGT) stands at a crossroads with its intriguing blend of clinical diagnostic and therapeutic development solutions. With a market capitalization of $595.17 million, this healthcare diagnostics..

Verve Therapeutics (VERV) Stock Analysis: Unveiling a 36.6% Potential Upside with Cutting-Edge Gene Editing Innovations

Verve Therapeutics, Inc. (NASDAQ: VERV) is capturing investor attention in the biotechnology sector with its promising gene editing medicines aimed at combating cardiovascular diseases. Operating from its base in Boston,..

Definitive Healthcare Corp. (DH) Stock Analysis: Navigating Through Headwinds with Strategic Insights

Definitive Healthcare Corp. (NASDAQ: DH) stands at a crucial juncture as it navigates the dynamic landscape of the healthcare information services industry. With a market capitalization of $450.84 million, the..

Prothena Corporation (PRTA) Stock Analysis: Exploring a Potential 269.65% Upside in Biotech

Prothena Corporation plc (NASDAQ: PRTA), a promising player in the biotechnology sector, is capturing investor attention with its remarkable 269.65% potential upside. Headquartered in Dublin, Ireland, Prothena is dedicated to..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a Potential 289% Upside

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) is capturing the attention of investors with its compelling growth potential in the biotechnology sector. With a market capitalization of $748.58 million, this healthcare..

Abivax SA (ABVX) Stock Analysis: Unveiling a 341% Upside Potential

For investors with a penchant for healthcare opportunities, Abivax SA (ABVX) presents an intriguing prospect in the biotechnology sector. Based in France, Abivax is a clinical-stage biotech company that focuses..

LifeMD, Inc. (LFMD) Stock Analysis: Telehealth Innovator with a Promising 48.8% Revenue Growth

LifeMD, Inc. (NASDAQ: LFMD) is emerging as a significant player in the rapidly evolving healthcare sector, specifically within the health information services industry. With a market capitalization of $551.86 million,..

COMPASS Pathways Plc (CMPS): Analyst Ratings Suggest 327% Upside Potential in Mental Health Breakthroughs

For investors seeking opportunities in the healthcare sector, COMPASS Pathways Plc (NASDAQ: CMPS) presents an intriguing case. As a pioneering biotechnology firm focused on mental health, COMPASS Pathways is capturing..

Nuvation Bio Inc. (NUVB) Stock Analysis: Exploring a 210% Potential Upside in the Biotech Sector

Nuvation Bio Inc. (NASDAQ: NUVB) stands out in the competitive biotech sector with a compelling story for investors seeking high-growth potential. As a clinical-stage biopharmaceutical company, Nuvation Bio focuses on..

Inventiva S.A. – American Depos (IVA) Stock Analysis: Unveiling a 222% Potential Upside in the Biotechnology Sector

Inventiva S.A. – American Depos (IVA) is a promising player in the biotechnology industry, attracting attention from investors seeking substantial growth in their portfolios. Headquartered in Daix, France, Inventiva is..

Tourmaline Bio, Inc. (TRML) Investor Outlook: Exploring a 220% Potential Upside in the Biotech Sector

Tourmaline Bio, Inc. (NASDAQ: TRML), a promising player in the biotechnology sector, is catching the attention of investors with its substantial potential upside. With a market capitalization of $449.31 million,..

Bicycle Therapeutics plc (BCYC) Stock Analysis: Unveiling a 224.76% Potential Upside in the Biotech Arena

Bicycle Therapeutics plc (NASDAQ: BCYC), a pioneering entity in the biotechnology sector, presents a compelling opportunity for investors seeking substantial growth in the healthcare industry. With its headquarters in Cambridge,..

Syndax Pharmaceuticals (SNDX) Stock Analysis: Exploring a 248% Potential Upside in Biotechnology

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is capturing the attention of investors with a compelling potential upside of 248%. As a commercial-stage biopharmaceutical company, Syndax focuses on the development of innovative..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring a 45% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) is making waves in the healthcare industry, specifically within the medical care facilities sector. With a market capitalization of $404.63 million, this U.S.-based company..

Butterfly Network, Inc. (BFLY) Stock Analysis: Unveiling a 122.82% Potential Upside in Medical Device Innovation

Butterfly Network, Inc. (NASDAQ: BFLY) has been gaining traction in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $443.46 million, this Burlington, Massachusetts-based company..

Surmodics, Inc. (SRDX) Investor Outlook: Navigating Challenges in the Medical Devices Sector

Surmodics, Inc. (NASDAQ: SRDX), a key player in the healthcare sector, is renowned for its innovative contributions to the medical devices industry. With a market capitalization of $446.15 million, the..

Sage Therapeutics, Inc. (SAGE): Investor Outlook and Ratings Reveal Limited Upside Potential

Investors navigating the dynamic field of biotechnology would do well to keep an eye on Sage Therapeutics, Inc. (NASDAQ: SAGE), a company specialized in brain health medicines. At a glance,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds